Cardioband™ shows promise at 1-year follow-up
October 18, 2018
Keywords: Transcatheter mitral valve repair; Cardioband; functional mitral regurgitation; 1-year outcomes
Cardioband implantation results in reasonable safety and performance at 1 year, according to a study published online in the European Heart Journal on 16 August 2018.
David Messika‑Zeitoun and colleagues from 11 European institutions reviewed the outcomes of 60 patients with moderate (27%) or severe (73%) secondary mitral regurgitation (MR) who were treated with Cardioband. Of the 39 patients who had a transthoracic echocardiogram at 1 year, 95% had an MR grade of moderate or less.
New York Heart Association Class and 6‑minute walk test distance significantly improved for most patients (p<0.01). In addition, quality of life was enhanced by an average of 19 points on the Minnesota Living with Heart Failure Questionnaire (p<0.01).
Although these early results are promising, further studies are required to confirm the device’s safety and effectiveness. A randomised controlled trial is underway to compare Cardioband plus guideline-directed medical therapy with guideline-directed medical therapy alone.